Han Kiat Ho
TitleCited byYear
Carbon nanotubes for delivery of small molecule drugs
BS Wong, SL Yoong, A Jagusiak, T Panczyk, HK Ho, WH Ang, G Pastorin
Advanced drug delivery reviews 65 (15), 1964-2015, 2013
3662013
Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models
CY Tan, RC Lai, W Wong, YY Dan, SK Lim, HK Ho
Stem cell research & therapy 5 (3), 76, 2014
2672014
Nanomaterial scaffolds for stem cell proliferation and differentiation in tissue engineering
C Zhao, A Tan, G Pastorin, HK Ho
Biotechnology advances 31 (5), 654-668, 2013
1742013
Public awareness of diabetes mellitus in Singapore
HL Wee, HK Ho, SC Li
Singapore medical journal 43 (3), 128-134, 2002
1612002
Thin films of functionalized multiwalled carbon nanotubes as suitable scaffold materials for stem cells proliferation and bone formation
TR Nayak, L Jian, LC Phua, HK Ho, Y Ren, G Pastorin
ACS nano 4 (12), 7717-7725, 2010
1582010
Bioactivation and hepatotoxicity of nitroaromatic drugs
UA Boelsterli, HK Ho, S Zhou, K Yeow Leow
Current drug metabolism 7 (7), 715-727, 2006
1562006
Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a …
HK Ho, S Pok, S Streit, JE Ruhe, S Hart, KS Lim, HL Loo, MO Aung, ...
Journal of hepatology 50 (1), 118-127, 2009
1452009
Mechanism-based inactivation of cytochrome P450 3A4 by lapatinib
WC Teng, JW Oh, LS New, MD Wahlin, SD Nelson, HK Ho, ECY Chan
Molecular pharmacology 78 (4), 693-703, 2010
952010
Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study
YT Cheung, T Ng, M Shwe, HK Ho, KM Foo, MT Cham, JA Lee, G Fan, ...
Annals of Oncology 26 (7), 1446-1451, 2015
942015
Genetic alterations in the tyrosine kinase transcriptome of human cancer cell lines
JE Ruhe, S Streit, S Hart, CH Wong, K Specht, P Knyazev, T Knyazeva, ...
Cancer research 67 (23), 11368-11376, 2007
932007
Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum (IV) prodrug of cisplatin
SL Yoong, BS Wong, QL Zhou, CF Chin, J Li, T Venkatesan, HK Ho, V Yu, ...
Biomaterials 35 (2), 748-759, 2014
732014
The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells
A Roidl, P Foo, W Wong, C Mann, S Bechtold, HJ Berger, S Streit, ...
Oncogene 29 (10), 1543, 2010
692010
Risk of tyrosine kinase inhibitors-induced hepatotoxicity in cancer patients: a meta-analysis
YL Teo, HK Ho, A Chan
Cancer treatment reviews 39 (2), 199-206, 2013
682013
Metabolism‐related pharmacokinetic drug− drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations
YL Teo, HK Ho, A Chan
British journal of clinical pharmacology 79 (2), 241-253, 2015
632015
Current strategies for inhibiting FGFR activities in clinical applications: opportunities, challenges and toxicological considerations
HK Ho, AHL Yeo, TS Kang, BT Chua
Drug discovery today 19 (1), 51-62, 2014
632014
Nrf2 activation involves an oxidative-stress independent pathway in tetrafluoroethylcysteine-induced cytotoxicity
HK Ho, CC White, C Fernandez, N Fausto, TJ Kavanagh, SD Nelson, ...
Toxicological Sciences 86 (2), 354-364, 2005
512005
Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness
F Peng, MI Setyawati, JK Tee, X Ding, J Wang, ME Nga, HK Ho, DT Leong
Nature nanotechnology 14 (3), 279-286, 2019
492019
Comparison of the cytotoxicity of the nitroaromatic drug flutamide to its cyano analogue in the hepatocyte cell line TAMH: evidence for complex I inhibition and mitochondrial …
KJ Coe, Y Jia, HK Ho, P Rademacher, TK Bammler, RP Beyer, FM Farin, ...
Chemical research in toxicology 20 (9), 1277-1290, 2007
492007
Cytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future research
YT Cheung, SR Lim, HK Ho, A Chan
PloS one 8 (12), e81234, 2013
462013
Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinoma
W Poh, W Wong, H Ong, MO Aung, SG Lim, BT Chua, HK Ho
Molecular cancer 11 (1), 14, 2012
452012
The system can't perform the operation now. Try again later.
Articles 1–20